Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives
2013 ◽
Vol 13
(5)
◽
pp. 625-636
◽
2014 ◽
Vol 45
(2)
◽
pp. 509-515
◽